Results 171 to 180 of about 825,388 (293)

Re‐Purposing Sapropterin (Kuvan) for ACTA2‐Related Multisystemic Smooth Muscle Dysfunction Syndrome: A Translational Mechanistic and First‐In‐Human Therapeutic Report

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Multisystemic smooth muscle dysfunction syndrome (MSMDS) is an ultra‐rare, ACTA2‐related disorder characterized by severe cerebrovascular disease, aortic aneurysms, and smooth muscle dysfunction. Using molecular dynamics simulations and in silico drug screening, we identified that sapropterin dihydrochloride (Kuvan) is a candidate capable of ...
Moran Hausman‐Kedem   +9 more
wiley   +1 more source

Controllable Transformation Matching Networks for Efficient RF Impedance Matching

open access: yes
Efficient and controlled delivery of radio-frequency (rf) power for semiconductor plasma processing typically relies upon tunable matching networks to transform the variable plasma load impedance to a fixed impedance suitable for most rf power amplifiers.
Rafa Islam, Khandoker N
core  

Digital non-Foster-inspired electronics for broadband impedance matching. [PDF]

open access: yesNat Commun
Yang X   +7 more
europepmc   +1 more source

Improved adaptive impedance matching for RF front-end systems of wireless transceivers. [PDF]

open access: yesSci Rep, 2020
Alibakhshikenari M   +6 more
europepmc   +1 more source

Augmenting and Assaying Nav1.1 Protein Quantity for Dravet Syndrome Therapy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Dravet Syndrome (DS) is a developmental and epileptic encephalopathy predominantly caused by heterozygous loss‐of‐function variants in SCN1A, which encodes Nav1.1. Conserved upstream open reading frames (uORFs) in SCN1A were validated to regulate translation in reporter assays, demonstrating the therapeutic viability of increasing Nav1.1 from ...
Aiswarya Saravanan   +7 more
wiley   +1 more source

Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son   +3 more
wiley   +1 more source

An impedance matching algorithm for common-mode interference removal in vagus nerve recordings. [PDF]

open access: yesJ Neurosci Methods, 2020
Levy TJ   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy